Vasculitic neuropathies
Vasculitic neuropathies, part of systemic vasculitis affecting various organs, present with acute, painful neuropathy and sensory deficits. Treatment targets the underlying condition with immunosuppressants like glucocorticoids or cyclophosphamide and symptom management. Pain is managed with drugs like pregabalin. Rehabilitation and monitoring through neurological exams are crucial for detecting and managing relapses.
Peripheral neuropathy
Peripheral neuropathy encompasses polyneuropathy, radiculopathy, and mononeuropathy, often presenting with symmetrical distal sensory loss, burning sensations, or motor weakness. Common causes include diabetes, renal impairment, amyloidosis, alcohol abuse, HIV, and certain medications. Treatment focuses on managing the underlying disease and symptom relief. Medications like gabapentin, duloxetine, pregabalin, and carbamazepine are used for symptom control, sometimes alongside tramadol, NSAIDs, or narcotics for pain. Severe cases may require surgical interventions like epidural injections. Physical therapy, foot care, and use of orthoses are important for lifestyle improvement and preventing complications like foot ulcers.
Multifocal motor neuropathy
Multifocal motor neuropathy (MMN) is a rare, slowly progressive disease characterized by asymmetric weakness and atrophy, predominantly in the arms and hands, without sensory loss. Often associated with anti-GM1 antibodies, MMN leads to disability if untreated. Treatment primarily involves intravenous immune globulin (IVIG), with maintenance infusions every two to six weeks. Alternatives like cyclophosphamide or rituximab have limited efficacy. Rehabilitation focuses on limb positioning, posture, orthotics, and exercise programs for fatigue management.
Miller Fisher syndrome
Miller Fisher syndrome, characterized by ophthalmoplegia, ataxia, and areflexia, often involves antibodies against GQ1b in 85-90% of cases. Its electrodiagnostic features include reduced or absent sensory responses without sensory conduction velocity slowing. Frequently linked to infections like Campylobacter jejuni or Epstein-Barr virus, MFS treatment aligns with Guillain-Barré syndrome, primarily involving plasmapheresis and intravenous immune globulin (IVIG).
Chronic inflammatory demyelinating polyneuropathy
Polyneuropathy encompasses various immune-mediated neuropathies, including Guillain-Barré syndrome (acute) and chronic inflammatory demyelinating polyneuropathy (CIDP). Other types include CIDP variants, multifocal motor neuropathy, conditions like MGUS, POEMS syndrome, neuropathy with IgM gammopathy, and Waldenström macroglobulinemia. Also involved are mixed cryoglobulinemia syndrome, GALOP syndrome, CANOMAD syndrome, primary amyloidosis, paraneoplastic neuropathies, and neuropathies associated with systemic autoimmune diseases. These present with diverse sensory, motor, or autonomic symptoms, and treatment is typically specific to the underlying cause.
Guillain Barré syndrome
Guillain-Barré syndrome (GBS) is characterized by progressive muscle weakness and diminished reflexes. Key treatment includes plasma exchange or IVIG, and supportive care in ICU or wards is crucial, focusing on respiratory, cardiac, and hemodynamic monitoring. Autonomic dysfunction and pain management are also critical aspects of care. Rehabilitation plays a vital role, and although relapses occur in some patients, treatment options for these cases are less clear.
Infectious neuropathy
The article outlines different neuropathic syndromes related to HIV and other infectious diseases. It emphasizes the prevalence of distal symmetric peripheral neuropathy (DSPN) in HIV patients, attributing it to factors like age, duration of HIV infection, and certain medications. Treatment for HIV-related neuropathy includes Antiretroviral therapy (ART), addressing reversible risk factors, and symptom management with medications like Gabapentin, duloxetine, venlafaxine, nortriptyline, and topical capsaicin cream.
Polyneuropathy
The article discusses various types of immune-related neuropathies. It begins with an overview of polyneuropathy, dividing it into acute (Guillain-Barré syndrome) and chronic forms (like chronic inflammatory demyelinating polyneuropathy). It then details specific neuropathies such as multifocal motor neuropathy, monoclonal gammopathy, POEMS syndrome, and others like Waldenström macroglobulinemia and mixed cryoglobulinemia syndrome. Each type is described in terms of symptoms, diagnosis, and treatment, highlighting their unique characteristics and management strategies.
Bell's palsy
Bell's palsy, the most common cause of acute spontaneous peripheral facial paralysis, is believed to involve inflammation and edema of the facial nerve, possibly related to herpes simplex virus reactivation. While most patients recover within several months to a year, up to a third experience chronic facial weakness, impacting function and appearance. Treatment primarily involves early short-term oral glucocorticoids, like prednisolone, and in severe cases, antiviral therapy with agents such as valacyclovir or acyclovir
Brachial plexitis
Brachial plexitis, which can be acute or gradual in onset, typically presents with shoulder or upper arm pain, and sometimes progressive numbness or muscle weakness. It is associated with various conditions including diabetes, inflammation (neuralgic amyotrophy), malignancies like lung and breast cancer, post-radiation, or trauma. Diagnosis is aided by nerve conduction studies and electromyography. Management generally involves conservative approaches, with physical therapy being central to alleviating pain, improving functionality, and maintaining range of motion. Treatment techniques include electrical nerve stimulation and cryotherapy. Pain relief is primarily achieved using non-steroidal anti-inflammatory drugs like naproxen, and in some cases, adjunctive therapies like glucocorticoids or narcotics for severe pain are employed.
Spinobulbar muscular atrophy
Spinobulbar muscular atrophy (Kennedy disease [KD]) is an X-linked disorder, typically manifesting between ages 20-60.
Spinal Muscular Atrophy
Spinal Muscular Atrophy (SMA) is a genetic disorder characterized by the progressive weakening and atrophy of muscles due to the degeneration of neurons in the spinal cord and lower brainstem. It presents in various forms, from prenatal onset to late adult onset, with symptoms including muscle weakness predominantly in the lower limbs, respiratory insufficiency, and normal cognitive function. Treatment for SMA involves supportive care to manage nutritional and respiratory needs, physical therapy, and potentially spinal bracing or surgery for scoliosis. Disease-modifying therapies like nusinersen and onasemnogene abeparvovec are used, alongside genetic counseling for affected individuals and their families.
Primary Lateral Sclerosis
Primary Lateral Sclerosis (PLS) is a neurodegenerative disease characterized by a slower progression compared to Amyotrophic Lateral Sclerosis (ALS) and primarily affects upper motor neurons. Its symptoms, which typically begin in the lower extremities, include spasticity, hyperreflexia, bladder instability, and urinary retention. Treatment for PLS, which lacks disease-modifying options, focuses on improving mobility and reducing spasticity through a combination of physical therapy, assistive devices, and medications like baclofen, tizanidine, and clonazepam. Management benefits from a multidisciplinary approach, similar to ALS care, but Riluzole, commonly used in ALS, has not shown significant benefits for PLS.
Amyotrophic Lateral Sclerosis
This article provides a comprehensive overview of Amyotrophic Lateral Sclerosis (ALS), a degenerative motor neuron disease characterized by symptoms like hyperreflexia, spasticity, and limb weakness. It emphasizes the need for a multidisciplinary management approach involving various healthcare professionals. The article details treatments like riluzole, edaravone, and investigational therapies, along with their dosages and side effects. It also discusses experimental therapies, symptom management strategies for respiratory issues, dysphagia, muscle spasms, fatigue, and pseudobulbar affect, and underscores the importance of palliative and hospice care.